Article
Predictive and prognostic factors for gliomas.
Expert review of anticancer therapy - 1 May 2011
Ducray François, Idbaih Ahmed, Wang Xiao-Wei, Cheneau Caroline, Labussiere Marianne, Sanson Marc
Abstract excerpt
Despite recent therapeutic advances, gliomas, in particular the most frequent and malignant glioblastoma, remain devastating tumors and need a better molecular characterization to improve both classification and treatment. Currently, three molecular markers, related to better outcome, are particularly useful and complement the histological classification: the 1p/19q codeletion strongly predicts prolonged response...
Topics
Join the communities discussing this publication.